Astrana Health (ASTH) Receivables (2011 - 2026)

Astrana Health (ASTH) has 16 years of Receivables data on file, last reported at $495.4 million in Q1 2026.

• Quarterly Receivables rose 93.52% year-over-year to $495.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $495.4 million (up 93.52% YoY) and the FY2025 annual result came in at $400.8 million, up 31.22% from the prior year.
• Receivables grew to $495.4 million in Q1 2026 per ASTH's latest filing, from $400.8 million in the prior quarter.
• The five-year high for Receivables was $495.4 million in Q1 2026, with the low at $20.4 million in Q3 2023.
• Average Receivables over 5 years is $172.9 million, with a median of $77.1 million recorded in 2024.
• Year-over-year, Receivables tumbled 63.7% in 2023 and surged 598.73% in 2025.
• Astrana Health's Receivables stood at $74.0 million in 2022, then decreased by 18.88% to $60.0 million in 2023, then jumped by 408.79% to $305.5 million in 2024, then surged by 31.22% to $400.8 million in 2025, then gained by 23.59% to $495.4 million in 2026.
• Business Quant data shows ASTH's Receivables at $495.4 million in Q1 2026, $400.8 million in Q4 2025, and $391.1 million in Q3 2025.